ArticleNPJ Parkinson's disease2025
Muscle bursting and corticomotor excitability mark impaired impulse control in Parkinson's disease.
Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- β-Bursting as a Sensitive Neural Marker of Inhibitory Control in Healthy Older Adults: A Linear Mixed-Effects Modeling and Threshold-Free Cluster Approach.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Dopamine agonists in Parkinson's disease increase the risk of impulse control disorders, yet the underlying neural mechanisms remain unclear. This study aimed to identify objective neurophysiological markers of impaired impulse control in Parkinson's linking to impulsivity problems. Nineteen people with Parkinson's (PwPD) on ropinirole and 18 healthy older adults performed an impulse control task requiring response withholding and inhibition. Transcranial magnetic stimulation was delivered, with corticomotor excitability (CME) and muscle bursts measured via electromyography. During response withholding, PwPD showed early relative increases in CME and more frequent dysfunctional muscle bursts, leading to more variable responses. During response inhibition, PwPD exhibited reduced CME suppression and increased muscle bursting, leading to delayed inhibition which was associated with problematic impulsive behaviours. The neurophysiological measures were associated with more advanced disease and may serve as early, objective markers of impulse control dysfunction, with future work required to assess their utility in predicting impulsive disorders.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.